Schedule 13G ownership disclosure

CANCER GENETICS INC.

Security class unavailable · CUSIP: 13739U104

Event date: 2016-11-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
736,076
Percent of class
3.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001552781-16-002091
Form type
SC 13G/A
Filer
Vyant Bio, Inc.
CIK
CIK 1349929
Filed
Nov 14, 2016
Reporting period
Nov 14, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub